As shown in Figure 4, breast cancer patients with higher expression level of TTC34 (Figure 4A), CNTRL (Figure 4B), TMEM151B (Figure 4C), hsa-miR-5691 (Figure 4D), and hsa-miR-92a-1-5p (Figure 4E) showed the higher OS. Here, TTC34 is linked to breast carcinoma.